chlorambucil and s 1033

chlorambucil has been researched along with s 1033 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Aloyz, R; Amrein, L; Davidson, D; Miller, WH; Panasci, L; Petruccelli, LA; Shawi, M1

Reviews

1 review(s) available for chlorambucil and s 1033

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for chlorambucil and s 1033

ArticleYear
Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy.
    Leukemia research, 2011, Volume: 35, Issue:8

    Topics: Antineoplastic Agents, Alkylating; B-Lymphocytes; Benzamides; Blotting, Western; Chlorambucil; Comet Assay; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imatinib Mesylate; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Recombination, Genetic; Tumor Cells, Cultured

2011